<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Inside the CDKL5 Gene Therapy Journey - January 15, 2026 | CDKL5 Gene Therapy</title>
    <meta name="description" content="A comprehensive look inside the CDKL5 Gene Therapy clinical dinner at UCSF. Learn about the Phase I trial, meet the clinical team, and understand what participation involves.">
    <link rel="stylesheet" href="css/style.css">
    <link rel="stylesheet" href="css/colors.css">
    <link href="https://fonts.googleapis.com/css2?family=Open+Sans:wght@300;400;600;700&display=swap" rel="stylesheet">
    <style>
        .event-hero {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            padding: 60px 20px;
            text-align: center;
        }
        .event-hero h1 {
            font-size: clamp(1.8rem, 4vw, 2.8rem);
            margin-bottom: 15px;
            line-height: 1.3;
        }
        .event-hero .subtitle {
            font-size: 1.2rem;
            opacity: 0.95;
            margin-bottom: 10px;
        }
        .event-meta-hero {
            display: flex;
            justify-content: center;
            gap: 30px;
            flex-wrap: wrap;
            font-size: 1rem;
            opacity: 0.9;
            margin-top: 20px;
        }
        .back-link {
            display: inline-flex;
            align-items: center;
            gap: 8px;
            color: white;
            opacity: 0.8;
            text-decoration: none;
            margin-bottom: 20px;
            font-size: 0.95rem;
        }
        .back-link:hover {
            opacity: 1;
        }
        .article-container {
            max-width: 800px;
            margin: 0 auto;
            padding: 50px 20px;
        }
        .article-container h2 {
            color: #333;
            font-size: 1.6rem;
            margin: 50px 0 20px 0;
            padding-bottom: 10px;
            border-bottom: 3px solid #667eea;
        }
        .article-container h2:first-of-type {
            margin-top: 0;
        }
        .article-container h3 {
            color: #444;
            font-size: 1.3rem;
            margin: 35px 0 15px 0;
        }
        .article-container p {
            color: #444;
            line-height: 1.9;
            margin-bottom: 20px;
            font-size: 1.05rem;
        }
        .article-container ul, .article-container ol {
            color: #444;
            line-height: 1.9;
            margin-bottom: 25px;
            padding-left: 25px;
        }
        .article-container li {
            margin-bottom: 12px;
        }
        .intro-box {
            background: linear-gradient(135deg, #f0f4ff 0%, #e8f5e9 100%);
            border-radius: 16px;
            padding: 30px;
            margin-bottom: 40px;
            border-left: 5px solid #667eea;
        }
        .intro-box p {
            margin-bottom: 0;
            font-size: 1.1rem;
            color: #333;
        }
        .highlight-box {
            background: #f8f9fa;
            border-radius: 12px;
            padding: 25px;
            margin: 25px 0;
            border-left: 4px solid #667eea;
        }
        .highlight-box p {
            margin-bottom: 10px;
        }
        .highlight-box ul {
            margin-bottom: 0;
        }
        .phase-cards {
            display: grid;
            gap: 20px;
            margin: 30px 0;
        }
        .phase-card {
            background: white;
            border-radius: 12px;
            padding: 25px;
            box-shadow: 0 4px 15px rgba(0,0,0,0.08);
            border-top: 4px solid #667eea;
        }
        .phase-card.phase-1 { border-top-color: #4CAF50; }
        .phase-card.phase-2 { border-top-color: #FF9800; }
        .phase-card.phase-3 { border-top-color: #9C27B0; }
        .phase-card h4 {
            color: #333;
            margin: 0 0 10px 0;
            font-size: 1.15rem;
        }
        .phase-card p {
            margin: 0;
            font-size: 0.95rem;
        }
        .qa-item {
            background: #fff;
            border-radius: 12px;
            padding: 25px;
            margin: 20px 0;
            box-shadow: 0 2px 10px rgba(0,0,0,0.06);
            border-left: 4px solid #667eea;
        }
        .qa-item .question {
            font-weight: 700;
            color: #333;
            margin-bottom: 12px;
            font-size: 1.1rem;
        }
        .qa-item .answer {
            color: #555;
            line-height: 1.8;
        }
        .team-photo {
            width: 100%;
            border-radius: 16px;
            box-shadow: 0 10px 40px rgba(0,0,0,0.15);
            margin: 30px 0;
        }
        .doctor-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(320px, 1fr));
            gap: 30px;
            margin: 40px 0;
        }
        .doctor-card {
            background: linear-gradient(145deg, #ffffff 0%, #f8f9ff 100%);
            border-radius: 20px;
            padding: 30px;
            box-shadow: 0 10px 40px rgba(102, 126, 234, 0.12);
            border: none;
            position: relative;
            overflow: hidden;
            transition: transform 0.3s ease, box-shadow 0.3s ease;
        }
        .doctor-card::before {
            content: '';
            position: absolute;
            top: 0;
            left: 0;
            right: 0;
            height: 6px;
            background: linear-gradient(90deg, #667eea 0%, #764ba2 100%);
        }
        .doctor-card:hover {
            transform: translateY(-5px);
            box-shadow: 0 20px 50px rgba(102, 126, 234, 0.2);
        }
        .doctor-icon {
            width: 60px;
            height: 60px;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            border-radius: 16px;
            display: flex;
            align-items: center;
            justify-content: center;
            margin-bottom: 20px;
            font-size: 1.8rem;
        }
        .doctor-card h4 {
            color: #2d3748;
            margin: 0 0 8px 0;
            font-size: 1.25rem;
            font-weight: 700;
        }
        .doctor-card .role {
            color: #667eea;
            font-weight: 600;
            font-size: 0.9rem;
            margin-bottom: 15px;
            display: inline-block;
            background: rgba(102, 126, 234, 0.1);
            padding: 6px 14px;
            border-radius: 20px;
        }
        .doctor-card p {
            font-size: 0.95rem;
            line-height: 1.7;
            margin-bottom: 20px;
            color: #4a5568;
        }
        .doctor-card a {
            color: white;
            text-decoration: none;
            font-weight: 600;
            font-size: 0.9rem;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            padding: 10px 20px;
            border-radius: 25px;
            display: inline-flex;
            align-items: center;
            gap: 8px;
            transition: transform 0.2s ease, box-shadow 0.2s ease;
        }
        .doctor-card a:hover {
            transform: translateY(-2px);
            box-shadow: 0 5px 20px rgba(102, 126, 234, 0.4);
        }
        .author-section {
            background: #f8f9fa;
            padding: 50px 20px;
            margin-top: 50px;
        }
        .author-container {
            max-width: 800px;
            margin: 0 auto;
        }
        .author-container h2 {
            text-align: center;
            color: #333;
            margin-bottom: 30px;
            font-size: 1.5rem;
        }
        .author-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(300px, 1fr));
            gap: 30px;
        }
        .author-card {
            background: white;
            border-radius: 16px;
            padding: 30px;
            box-shadow: 0 4px 20px rgba(0,0,0,0.08);
            text-align: center;
        }
        .author-photo {
            width: 120px;
            height: 120px;
            border-radius: 50%;
            object-fit: cover;
            margin: 0 auto 20px;
            border: 4px solid #667eea;
            box-shadow: 0 8px 25px rgba(102, 126, 234, 0.3);
        }
        .author-card h3 {
            color: #333;
            margin: 0 0 10px 0;
        }
        .author-card p {
            color: #555;
            font-size: 0.95rem;
            line-height: 1.7;
        }
        .donate-cta {
            background: linear-gradient(135deg, #ff6b35 0%, #f7931e 100%);
            padding: 60px 20px;
            text-align: center;
            color: white;
        }
        .donate-cta h2 {
            font-size: 2rem;
            margin-bottom: 15px;
        }
        .donate-cta p {
            font-size: 1.15rem;
            opacity: 0.95;
            max-width: 600px;
            margin: 0 auto 30px;
            line-height: 1.7;
        }
        .donate-btn {
            display: inline-flex;
            align-items: center;
            gap: 12px;
            background: white;
            color: #ff6b35;
            padding: 18px 45px;
            border-radius: 50px;
            text-decoration: none;
            font-weight: 700;
            font-size: 1.25rem;
            transition: transform 0.3s, box-shadow 0.3s;
        }
        .donate-btn:hover {
            transform: translateY(-3px);
            box-shadow: 0 15px 40px rgba(0,0,0,0.25);
        }
        .donate-cta .goal-text {
            margin-top: 20px;
            font-size: 0.95rem;
            opacity: 0.9;
        }
        .pdf-section {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            padding: 50px 20px;
            text-align: center;
            color: white;
        }
        .pdf-section h2 {
            margin-bottom: 15px;
        }
        .pdf-section p {
            opacity: 0.9;
            margin-bottom: 25px;
            max-width: 600px;
            margin-left: auto;
            margin-right: auto;
        }
        .pdf-btn {
            display: inline-flex;
            align-items: center;
            gap: 12px;
            background: linear-gradient(135deg, #fff 0%, #f0f4ff 100%);
            color: #667eea;
            padding: 20px 45px;
            border-radius: 50px;
            text-decoration: none;
            font-weight: 700;
            font-size: 1.2rem;
            transition: transform 0.3s, box-shadow 0.3s;
            border: 3px solid rgba(255,255,255,0.5);
            cursor: pointer;
            box-shadow: 0 8px 30px rgba(0,0,0,0.2), 0 0 0 4px rgba(255,255,255,0.3);
            animation: pulse-glow 2s ease-in-out infinite;
        }
        @keyframes pulse-glow {
            0%, 100% {
                box-shadow: 0 8px 30px rgba(0,0,0,0.2), 0 0 0 4px rgba(255,255,255,0.3);
            }
            50% {
                box-shadow: 0 8px 40px rgba(0,0,0,0.3), 0 0 0 8px rgba(255,255,255,0.4), 0 0 30px rgba(255,255,255,0.3);
            }
        }
        .pdf-btn:hover {
            transform: translateY(-5px) scale(1.05);
            box-shadow: 0 15px 40px rgba(0,0,0,0.3), 0 0 0 6px rgba(255,255,255,0.5);
            animation: none;
        }
        .pdf-btn svg {
            width: 24px;
            height: 24px;
        }
        .contact-box {
            background: #e8f5e9;
            border-radius: 12px;
            padding: 25px;
            margin: 30px 0;
            text-align: center;
        }
        .contact-box a {
            color: #667eea;
            font-weight: 600;
        }
        
        /* PDF Download Modal */
        .pdf-modal {
            display: none;
            position: fixed;
            top: 0;
            left: 0;
            width: 100%;
            height: 100%;
            background: rgba(0,0,0,0.6);
            z-index: 9999;
            justify-content: center;
            align-items: center;
        }
        .pdf-modal.active {
            display: flex;
        }
        .pdf-modal-content {
            background: white;
            border-radius: 16px;
            padding: 30px;
            max-width: 450px;
            width: 90%;
            box-shadow: 0 20px 60px rgba(0,0,0,0.3);
            position: relative;
            max-height: 90vh;
            overflow-y: auto;
        }
        .pdf-modal-close {
            position: absolute;
            top: 15px;
            right: 15px;
            background: none;
            border: none;
            font-size: 24px;
            cursor: pointer;
            color: #666;
        }
        .pdf-modal h3 {
            margin: 0 0 10px 0;
            color: #333;
        }
        .pdf-modal p {
            color: #666;
            margin-bottom: 20px;
            font-size: 0.95rem;
        }
        .pdf-form-group {
            margin-bottom: 15px;
        }
        .pdf-form-group label {
            display: block;
            margin-bottom: 5px;
            font-weight: 600;
            color: #333;
            font-size: 0.9rem;
        }
        .pdf-form-group input,
        .pdf-form-group select,
        .pdf-form-group textarea {
            width: 100%;
            padding: 12px;
            border: 1px solid #ddd;
            border-radius: 8px;
            font-size: 1rem;
            box-sizing: border-box;
        }
        .pdf-form-group textarea {
            resize: vertical;
            min-height: 80px;
        }
        .pdf-submit-btn {
            width: 100%;
            padding: 14px;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            border: none;
            border-radius: 8px;
            font-size: 1rem;
            font-weight: 600;
            cursor: pointer;
            display: flex;
            align-items: center;
            justify-content: center;
            gap: 8px;
        }
        .pdf-submit-btn:hover {
            opacity: 0.9;
        }
        
        /* Social Share Buttons */
        .social-share {
            display: flex;
            justify-content: center;
            gap: 15px;
            margin-top: 25px;
        }
        .social-share a {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 45px;
            height: 45px;
            border-radius: 50%;
            background: rgba(255,255,255,0.2);
            color: white;
            text-decoration: none;
            transition: transform 0.3s, background 0.3s;
        }
        .social-share a:hover {
            transform: translateY(-3px);
            background: rgba(255,255,255,0.35);
        }
        .social-share svg {
            width: 22px;
            height: 22px;
            fill: currentColor;
        }
        .reading-time {
            display: inline-block;
            background: rgba(255,255,255,0.2);
            padding: 6px 16px;
            border-radius: 20px;
            font-size: 0.9rem;
            margin-top: 15px;
        }
        
        /* Back to Top Button */
        .back-to-top {
            position: fixed;
            bottom: 30px;
            right: 30px;
            width: 50px;
            height: 50px;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            border: none;
            border-radius: 50%;
            cursor: pointer;
            display: flex;
            align-items: center;
            justify-content: center;
            box-shadow: 0 4px 15px rgba(0,0,0,0.2);
            opacity: 0;
            visibility: hidden;
            transition: opacity 0.3s, visibility 0.3s, transform 0.3s;
            z-index: 1000;
        }
        .back-to-top.visible {
            opacity: 1;
            visibility: visible;
        }
        .back-to-top:hover {
            transform: translateY(-3px);
            box-shadow: 0 6px 20px rgba(0,0,0,0.3);
        }
        .back-to-top svg {
            width: 24px;
            height: 24px;
        }
        
        @media (max-width: 600px) {
            .event-hero { padding: 40px 15px; }
            .article-container { padding: 30px 15px; }
            .donate-cta h2 { font-size: 1.6rem; }
            .donate-btn { padding: 15px 35px; font-size: 1.1rem; }
            .back-to-top { bottom: 20px; right: 20px; width: 45px; height: 45px; }
            .social-share a { width: 40px; height: 40px; }
            .gallery-nav { width: 40px; height: 40px; }
        }

        /* Event Photo Gallery */
        .event-gallery {
            margin: 40px 0;
            position: relative;
        }
        .event-gallery h3 {
            text-align: center;
            color: #333;
            margin-bottom: 25px;
            font-size: 1.4rem;
        }
        .gallery-container {
            position: relative;
            max-width: 700px;
            margin: 0 auto;
            overflow: hidden;
            border-radius: 16px;
            box-shadow: 0 15px 50px rgba(102, 126, 234, 0.2);
        }
        .gallery-slides {
            display: flex;
            transition: transform 0.5s ease-in-out;
        }
        .gallery-slide {
            min-width: 100%;
            position: relative;
        }
        .gallery-slide img {
            width: 100%;
            height: 450px;
            object-fit: cover;
            display: block;
        }
        .gallery-nav {
            position: absolute;
            top: 50%;
            transform: translateY(-50%);
            width: 50px;
            height: 50px;
            background: rgba(255,255,255,0.95);
            border: none;
            border-radius: 50%;
            cursor: pointer;
            display: flex;
            align-items: center;
            justify-content: center;
            box-shadow: 0 4px 15px rgba(0,0,0,0.15);
            transition: all 0.3s ease;
            z-index: 10;
        }
        .gallery-nav:hover {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            transform: translateY(-50%) scale(1.1);
        }
        .gallery-nav.prev { left: 15px; }
        .gallery-nav.next { right: 15px; }
        .gallery-nav svg {
            width: 24px;
            height: 24px;
        }
        .gallery-dots {
            display: flex;
            justify-content: center;
            gap: 10px;
            margin-top: 20px;
        }
        .gallery-dot {
            width: 12px;
            height: 12px;
            border-radius: 50%;
            background: #ddd;
            border: none;
            cursor: pointer;
            transition: all 0.3s ease;
        }
        .gallery-dot.active {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            transform: scale(1.2);
        }
        .gallery-dot:hover {
            background: #667eea;
        }
        .gallery-caption {
            text-align: center;
            color: #666;
            font-size: 0.95rem;
            margin-top: 15px;
            font-style: italic;
        }
    </style>
</head>
<body>
    <div data-include="inc/header.html"></div>

    <!-- Hero Section -->
    <section class="event-hero">
        <a href="past-events.html" class="back-link">
            ‚Üê Back to All Past Events
        </a>
        <h1>Inside the CDKL5 Gene Therapy Journey</h1>
        <p class="subtitle">By Nyesha Bahl & Nicholas Schein</p>
        <div class="event-meta-hero">
            <span>üìÖ January 15, 2026</span>
            <span>üìç University of California San Francisco</span>
        </div>
        <span class="reading-time">üìñ ~15 minute read</span>
        
        <!-- Social Share Buttons -->
        <div class="social-share">
            <a href="https://www.facebook.com/sharer/sharer.php?u=https://cdkl5genetherapy.com/event-clinical-team-jan2026.html" target="_blank" title="Share on Facebook">
                <svg viewBox="0 0 24 24"><path d="M18.77 7.46H14.5v-1.9c0-.9.6-1.1 1-1.1h3V.5h-4.33C10.24.5 9.5 3.44 9.5 5.32v2.15h-3v4h3v12h5v-12h3.85l.42-4z"/></svg>
            </a>
            <a href="https://twitter.com/intent/tweet?url=https://cdkl5genetherapy.com/event-clinical-team-jan2026.html&text=Inside the CDKL5 Gene Therapy Journey - A comprehensive look at the Phase I clinical trial" target="_blank" title="Share on X (Twitter)">
                <svg viewBox="0 0 24 24"><path d="M18.244 2.25h3.308l-7.227 8.26 8.502 11.24H16.17l-5.214-6.817L4.99 21.75H1.68l7.73-8.835L1.254 2.25H8.08l4.713 6.231zm-1.161 17.52h1.833L7.084 4.126H5.117z"/></svg>
            </a>
            <a href="https://www.linkedin.com/sharing/share-offsite/?url=https://cdkl5genetherapy.com/event-clinical-team-jan2026.html" target="_blank" title="Share on LinkedIn">
                <svg viewBox="0 0 24 24"><path d="M20.5 2h-17A1.5 1.5 0 002 3.5v17A1.5 1.5 0 003.5 22h17a1.5 1.5 0 001.5-1.5v-17A1.5 1.5 0 0020.5 2zM8 19H5v-9h3zM6.5 8.25A1.75 1.75 0 118.3 6.5a1.78 1.78 0 01-1.8 1.75zM19 19h-3v-4.74c0-1.42-.6-1.93-1.38-1.93A1.74 1.74 0 0013 14.19a.66.66 0 000 .14V19h-3v-9h2.9v1.3a3.11 3.11 0 012.7-1.4c1.55 0 3.36.86 3.36 3.66z"/></svg>
            </a>
            <a href="mailto:?subject=Inside the CDKL5 Gene Therapy Journey&body=Check out this article about the CDKL5 gene therapy clinical trial: https://cdkl5genetherapy.com/event-clinical-team-jan2026.html" title="Share via Email">
                <svg viewBox="0 0 24 24"><path d="M20 4H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h16c1.1 0 2-.9 2-2V6c0-1.1-.9-2-2-2zm0 4l-8 5-8-5V6l8 5 8-5v2z"/></svg>
            </a>
        </div>
    </section>

    <main>
        <article class="article-container">
            
            <!-- Introduction -->
            <div class="intro-box">
                <p><strong>CDKL5 Deficiency Disorder (CDD)</strong> is a rare genetic condition affecting about 1 in 40,000 children, leading to severe developmental delays and seizures due to mutations in the CDKL5 gene. For families living with CDD, hope has often arrived with uncertainty.</p>
            </div>

            <p>Over the years, many parents have watched promising research programs appear, stall, or quietly disappear‚Äîusually for reasons that had little to do with science and everything to do with business priorities of the research institutes and medical offices. That history is precisely why this CDKL5 Gene Therapy effort by the Child's Cure Genetic Research Foundation exists, partnering with the UCSF clinical team to advance a program that builds on established science, brings gene therapy from the lab to the clinic, and communicates every step with careful, responsible, and transparent intent.</p>

            <h2>The Clinical Dinner</h2>
            
            <p>On January 15, 2026, families gathered virtually and in person for a UCSF Clinical Dinner, where a "working draft" of the planned Phase I clinical trial was presented. The event featured key members of the UCSF clinical team:</p>

            <img src="images/team/clinical-team.jpg" alt="CDKL5 Clinical Team at UCSF - Dr. Nalin Gupta, Dr. Adam Numis, Dr. Kazim Narsinh" class="team-photo">

            <div class="doctor-grid">
                <div class="doctor-card">
                    <div class="doctor-icon">üß†</div>
                    <h4>Dr. Nalin Gupta</h4>
                    <div class="role">Pediatric Neurosurgeon</div>
                    <p>Chief of Pediatric Neurological Surgery at UCSF and pioneer in delivering therapies directly to the brain. Principal Investigator leading numerous clinical trials for rare pediatric brain diseases.</p>
                    <a href="https://profiles.ucsf.edu/nalin.gupta" target="_blank">View Profile ‚Üó</a>
                </div>
                <div class="doctor-card">
                    <div class="doctor-icon">‚ö°</div>
                    <h4>Dr. Adam Numis</h4>
                    <div class="role">Epilepsy Specialist</div>
                    <p>Pediatric epilepsy specialist leading seizure monitoring and neurologic assessments in the trial. Expert in epilepsy care and outcome measures for children with CDKL5.</p>
                    <a href="https://profiles.ucsf.edu/adam.numis" target="_blank">View Profile ‚Üó</a>
                </div>
                <div class="doctor-card">
                    <div class="doctor-icon">üìä</div>
                    <h4>Dr. Kazim Narsinh</h4>
                    <div class="role">Neurointerventional Radiologist</div>
                    <p>Neuroradiologist interpreting imaging for safety and vector distribution. Expert in pediatric brain imaging and safety assessments for clinical trials.</p>
                    <a href="https://profiles.ucsf.edu/kazim.narsinh" target="_blank">View Profile ‚Üó</a>
                </div>
            </div>

            <p>Jainu Jogani, co-founder of Child's Cure Genetic Research Foundation, provided an overview of the CDKL5 gene therapy project, its current status, and next steps. Industry partners from <strong>Charles River Laboratories</strong>, <strong>iXCell Biotechnologies</strong>, <strong>UCSF Catalyst</strong>, and <strong>uBrigene</strong> also attended, highlighting the collaborative effort behind this initiative.</p>

            <p>The purpose of the meeting was to explain what is being built, why certain decisions are being made, and what participation in a first-in-human gene therapy trial would truly involve.</p>

            <!-- Event Photo Gallery -->
            <div class="event-gallery">
                <h3>üì∏ Moments from the Event</h3>
                <div class="gallery-container">
                    <div class="gallery-slides" id="gallerySlides">
                        <div class="gallery-slide">
                            <img src="images/events/15_jan_event.jpeg" alt="CDKL5 Clinical Dinner - January 15, 2026">
                        </div>
                        <div class="gallery-slide">
                            <img src="images/events/15_jan_event1.jpeg" alt="Families and clinical team discussion">
                        </div>
                        <div class="gallery-slide">
                            <img src="images/events/15_jan_event2.jpeg" alt="UCSF presentation on gene therapy">
                        </div>
                        <div class="gallery-slide">
                            <img src="images/events/15_jan_event3.jpeg" alt="Q&A session with doctors">
                        </div>
                        <div class="gallery-slide">
                            <img src="images/events/15_jan_event4.jpeg" alt="Community gathering at UCSF">
                        </div>
                        <div class="gallery-slide">
                            <img src="images/events/15_jan_event5.jpeg" alt="Clinical dinner presentation">
                        </div>
                        <div class="gallery-slide">
                            <img src="images/events/15_jan_event6.jpeg" alt="Families connecting at the event">
                        </div>
                    </div>
                    <button class="gallery-nav prev" onclick="changeSlide(-1)">
                        <svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2.5">
                            <polyline points="15 18 9 12 15 6"></polyline>
                        </svg>
                    </button>
                    <button class="gallery-nav next" onclick="changeSlide(1)">
                        <svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2.5">
                            <polyline points="9 18 15 12 9 6"></polyline>
                        </svg>
                    </button>
                </div>
                <div class="gallery-dots" id="galleryDots">
                    <button class="gallery-dot active" onclick="goToSlide(0)"></button>
                    <button class="gallery-dot" onclick="goToSlide(1)"></button>
                    <button class="gallery-dot" onclick="goToSlide(2)"></button>
                    <button class="gallery-dot" onclick="goToSlide(3)"></button>
                    <button class="gallery-dot" onclick="goToSlide(4)"></button>
                    <button class="gallery-dot" onclick="goToSlide(5)"></button>
                    <button class="gallery-dot" onclick="goToSlide(6)"></button>
                </div>
                <p class="gallery-caption">Photos from the January 15, 2026 Clinical Dinner at UCSF</p>
            </div>

            <h2>The Science: Why Gene Therapy?</h2>

            <p>CDKL5 gene therapy aims to replace the dysfunctional gene with a healthy copy, addressing the root cause of CDD. The CDKL5 protein supports dendrite branching and synapse formation, and by delivering a functional version via an <strong>Adeno-Associated Virus serotype 9 (AAV9)</strong> vector, the therapy targets widespread brain networks affected by the disorder.</p>

            <p>This gene therapy is not fundamentally different from previous CDKL5 programs. There are only a few proven ways to deliver genes safely into the brain today, and this program uses AAV9, the same vector class used in many prior efforts. AAV9 acts like a tiny delivery boat, carrying a healthy CDKL5 gene to brain cells. Once it reaches the neurons, this gene starts producing a protein that helps grow brain connections and keeps signals steady.</p>

            <p><strong>What is different is execution.</strong> Previous programs did not reach clinical trials, often because of shifting corporate priorities or financial models that did not favor rare diseases. This parent-led effort exists to finish the work‚Äîto take what science already knows how to do and carry it across the final, difficult threshold into human trials.</p>

            <div class="highlight-box">
                <p><strong>Key Milestones Achieved:</strong></p>
                <ul>
                    <li>Successful vector design and development for CDKL5 protein expression</li>
                    <li>Proof-of-concept efficacy studies in CDKL5 mouse models and iPSC cell lines showing functional restoration</li>
                    <li>Completion of pre-IND discussions with the FDA</li>
                    <li>Finalization of the clinical protocol synopsis outlining the trial's structure and endpoints</li>
                    <li>Development of the groundbreaking CDKL5 pig model‚Äîthe first of its kind</li>
                </ul>
            </div>

            <h3>Why Gene Therapy Over Stem Cells?</h3>

            <p>The clinical team explained that stem cell approaches work best when targeting very specific brain regions. In disorders like CDD, where seizures arise from complex networks and the impact is widespread, stem cell deployment across all brain regions is far more complex. They also bring added challenges: immune reaction to stem cells, uncertainty about how they integrate, and limited evidence of benefit in genetic epilepsies. For CDKL5, gene replacement remains the most feasible way to address the disorder's root cause.</p>

            <h2>Understanding the Trial Phases</h2>

            <p>The ideal is to execute this program in 3 phases:</p>

            <div class="phase-cards">
                <div class="phase-card phase-1">
                    <h4>Phase 1 ‚Äì Safety First</h4>
                    <p>A small, carefully selected group is treated to ensure the therapy can be delivered safely. While not designed to prove success, any strong signal‚Äîlike a clear reduction in seizures‚Äîwould be highly meaningful.</p>
                </div>
                <div class="phase-card phase-2">
                    <h4>Phase 2 ‚Äì Evidence of Impact</h4>
                    <p>Builds on Phase 1 by using early signals and biomarkers to refine dosing and design, helping show whether the therapy is consistently working and how best to measure its effects.</p>
                </div>
                <div class="phase-card phase-3">
                    <h4>Phase 3 ‚Äì Proof at Scale</h4>
                    <p>A larger, longer "pivotal" study designed to definitively prove effectiveness on stopping seizures and safety over time, providing the evidence needed for potential regulatory approval.</p>
                </div>
            </div>

            <h2>Costs & Funding: The "Functional House" Philosophy</h2>

            <p>A pivotal part of the conversation centered on cost. Families have heard that gene therapy programs often cost $20‚Äì30 million. Why, then, is this program raising $3.5 million?</p>

            <p>This fundraising goal is intended to support Phase 1 and Phase 2 with a small number of participants. It does not attempt to fund every phase in advance. The UCSF team explained that much of the cost in gene therapy trials comes from what is included per patient: anesthesia, imaging, lab monitoring, inpatient care, long-term follow-up, and the specialized personnel required for a high-risk study.</p>

            <p>Another rare disease program, FOXG1, is raising around $22 million because it plans to fund all phases at once, including Phase 3. The physicians offered an analogy that perfectly captured the philosophy:</p>

            <div class="highlight-box">
                <p><em>"You can buy an expensive house with a porch and a view, or you can buy a functional home that meets your needs. This program is building a functional house: a trial that ensures safety and meaningful outcomes, without adding every possible test that might inflate costs and slow progress."</em></p>
            </div>

            <p>Core endpoints focus on seizure reduction as the primary measure, and biomarkers including phosphorylated EB2‚Äîa bonafide downstream target of CDKL5. If CDKL5 protein is present and working, EB2 will show up in CSF, making this an important biomarker confirming if CDKL5 is expressed and working properly. Blood and spinal fluid can be stored for later analysis rather than running every expensive assay immediately.</p>

            <h2>The Inpatient Experience</h2>

            <p>The CDKL5 Gene Therapy process would begin with pre-infusion assessments and pre-medication. Here's what families can expect:</p>

            <h3>Pre-Infusion (Day -1 to 0)</h3>
            <p>Assessments of vital signs, blood draws, weight checks, and pre-medication like steroids to mitigate immune responses to the viral vector.</p>

            <h3>Day of Administration (Day 0)</h3>
            <p>The child is asleep under anesthesia in an interventional suite. The gene therapy is delivered once via the intracisterna magna route, guided by imaging. Continuous monitoring follows for any reactions.</p>

            <h3>Post-Infusion (Day 1+)</h3>
            <p>Safety surveillance covers indicators like liver enzymes and immune markers, alongside seizure management in a family-centered setting where parents can stay bedside.</p>

            <h3>Discharge & Follow-Up</h3>
            <p>Discharge occurs once the child is clinically stable, with clear medication instructions (e.g., tapering steroids), emergency protocols, and scheduled post-discharge follow-ups. Long-term monitoring continues at 3, 6, 12, and 24 months through a combination of in-person and virtual visits.</p>

            <h2>Eligibility & Enrollment</h2>

            <p>Eligibility criteria, still under development and subject to UCSF IRB and FDA review, will ensure a homogeneous study population for reliable data. Categories include:</p>

            <ul>
                <li><strong>Demographics:</strong> Minimum age of 5 years, all genders</li>
                <li><strong>Diagnosis:</strong> Confirmed CDKL5 diagnosis</li>
                <li><strong>Disease Severity:</strong> Such as seizure frequency</li>
                <li><strong>Overall Health:</strong> Comorbidities assessment</li>
                <li><strong>Prior Treatments:</strong> Medical history review</li>
                <li><strong>Study Requirements:</strong> Ability to meet commitments</li>
            </ul>

            <p>Enrollment is a multi-stage process: initial pre-screening via UCSF's survey, formal clinical evaluation, informed consent discussions, and final eligibility confirmation with safety clearances.</p>

            <p>Details will be available on <a href="https://clinicaltrials.ucsf.edu" target="_blank">ClinicalTrials.UCSF.edu</a>, <a href="https://clinicaltrials.gov" target="_blank">ClinicalTrials.gov</a>, and updates on <a href="https://cdkl5genetherapy.com" target="_blank">CDKL5GeneTherapy.com</a>.</p>

            <h2>Parent Q&A Highlights</h2>

            <div class="qa-item">
                <div class="question">Could giving too much or too little of the gene be harmful?</div>
                <div class="answer">This is why extensive animal studies are essential. They guide dose selection so that the first human dose is conservative‚Äîsmall enough to be safe, yet large enough to plausibly have an effect. Early-phase trials proceed cautiously. If safety is established, future groups may receive adjusted doses based on what is learned. This stepwise approach is fundamental to gene therapy.</div>
            </div>

            <div class="qa-item">
                <div class="question">Could gene therapy "reset" a child, wiping out hard-won skills?</div>
                <div class="answer">Gene therapy is not one uniform thing. Each gene has a different role. Effects depend on where and how that gene is expressed. The field is still learning what happens when a working gene is introduced into a brain that has never had it. There is no known pattern of gene therapy causing a universal "system reset," but variability is real. That uncertainty is exactly why Phase 1 exists, why long-term monitoring matters, and why safety is of utmost importance.</div>
            </div>

            <div class="qa-item">
                <div class="question">How close to the center do participants need to be?</div>
                <div class="answer">While exact details are yet to be finalized, families would need to stay within a 45-minute drive from the hospital for a week post-treatment. Some of the funding for these studies may go towards supporting travel for families further away.</div>
            </div>

            <div class="qa-item">
                <div class="question">What are the risks involved?</div>
                <div class="answer">Risks include bleeding, infection, and cerebrospinal fluid leakage when delivering therapy near the brain. These risks are rare, but they can occur. There are also immune risks related to the AAV9 vector. While the delivered gene is simply DNA, the body may recognize viral components and create an immune response. This is why steroids or anti-inflammatory medications are used, and patients will be closely monitored for the duration of the trial.</div>
            </div>

            <h2>What Parents Can Do Today</h2>

            <div class="highlight-box">
                <ul>
                    <li><strong>Keep a detailed seizure diary.</strong> Stability in baseline data is crucial for measuring change.</li>
                    <li><strong>Maintain consistent routines and medications</strong> unless your clinician directs otherwise during the baseline period.</li>
                    <li><strong>Stay engaged</strong> as the criteria become final.</li>
                    <li><strong>Most importantly‚Äîhelp fund the path to the clinic.</strong> This program exists because families decided not to wait passively.</li>
                </ul>
            </div>
            
            <div style="text-align: center; margin: 30px 0;">
                <a href="donate.html" class="btn" style="display: inline-flex; align-items: center; gap: 10px; background: linear-gradient(135deg, #ff6b35 0%, #f7931e 100%); color: white; padding: 15px 35px; border-radius: 50px; text-decoration: none; font-weight: 700; font-size: 1.1rem; transition: transform 0.3s, box-shadow 0.3s;">
                    üíú Donate Now
                </a>
            </div>

            <div class="contact-box">
                <p><strong>Questions?</strong> For any clinical or non-clinical questions, reach out to <a href="mailto:cdkl5@childscure.org">cdkl5@childscure.org</a></p>
                <p>Be sure to check out the <a href="frequently-asked-questions.html">FAQs page</a></p>
            </div>

            <h2>A Note from the Foundation</h2>

            <p>The foundation's commitment to the CDKL5 community was emphasized, acknowledging past timeline shifts in clinical development that have challenged families. Milestones are shared only when finalized. Teams are working with urgency, extending schedules to speed the transition from bench to bedside.</p>

            <p>This meeting was a working session with the people designing a serious clinical study. It reflected determination, realism, and responsibility. The foundation made clear that it welcomes collaboration from any organization willing to help. The UCSF team emphasized its role: to build the safest possible study with the highest likelihood of answering the questions that matter.</p>

            <div style="text-align: center; margin: 30px 0;">
                <a href="mailto:cdkl5@childscure.org?subject=Collaboration Inquiry - CDKL5 Gene Therapy" class="btn" style="display: inline-flex; align-items: center; gap: 10px; background: linear-gradient(135deg, #667eea 0%, #764ba2 100%); color: white; padding: 15px 35px; border-radius: 50px; text-decoration: none; font-weight: 700; font-size: 1rem; transition: transform 0.3s, box-shadow 0.3s;">
                    ü§ù Join Our Mission
                </a>
            </div>

            <p><em>We are incredibly grateful to the families and clinical partners who made this possible.</em></p>

        </article>

        <!-- Authors Section -->
        <section class="author-section">
            <div class="author-container">
                <h2>About the Authors</h2>
                <div class="author-grid">
                    <div class="author-card">
                        <img src="images/team/Nysha_bahl.jpeg" alt="Nyesha Bahl" class="author-photo">
                        <h3>Nyesha Bahl</h3>
                        <p>Nyesha is a high school student with a strong passion for neuroscience, genetics, psychology, and sports medicine, driven by a desire to understand how the brain and body work and how science can improve lives. She actively pursues these interests through advanced coursework, Science Olympiad, and academic enrichment programs. Beyond academics, Nyesha volunteers with Friends of Children with Special Needs (FCSN), where she works closely with children to support life skills and confidence, and creates exercise videos specifically designed for people with cerebral palsy. A nationally competitive cricketer who has competed in elite tournaments across the United States, she brings discipline, resilience, and leadership to everything she does, with a long-term goal of building a career in neuroscience, genetic engineering, or sports medicine.</p>
                    </div>
                    <div class="author-card">
                        <img src="images/team/Nicolas.jpeg" alt="Nicholas Schein" class="author-photo">
                        <h3>Nicholas Schein</h3>
                        <p>Nick graduated with a BS in Cognitive Science from Lehigh University in May 2025. He is interested in researching the relationship between epilepsy/epileptogenesis and aging, particularly via hiPSC-derived brain organoids. Nick may eventually focus on determining mechanisms of epilepsy and epileptogenesis in "rare" and medically intractable epilepsies (LGS, Dravet, MAE, SCN8A, etc.). He is currently building experience with laboratory and research techniques at the Buck Institute for Research on Aging until May 2026 before applying to full-time RA positions at institutions like UCSF, Gladstone, Stanford, and others. After obtaining RA experience, Nick intends to apply for the 2027 PhD cycle.</p>
                    </div>
                </div>
            </div>
        </section>

        <!-- PDF Download Section -->
        <section class="pdf-section">
            <h2>Get the Presentation Slides</h2>
            <p>Access the Clinical Trial Readiness Overview slides from this event.</p>
            <button class="pdf-btn" onclick="openPdfModal()">
                <svg width="20" height="20" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2">
                    <path d="M21 15v4a2 2 0 0 1-2 2H5a2 2 0 0 1-2-2v-4"></path>
                    <polyline points="7 10 12 15 17 10"></polyline>
                    <line x1="12" y1="15" x2="12" y2="3"></line>
                </svg>
                Download PDF
            </button>
        </section>

        <!-- Donate CTA -->
        <section class="donate-cta">
            <h2>üíú Help Us Reach the Clinic</h2>
            <p>This program exists because families decided not to wait passively. Your donation brings us one step closer to the first-in-human CDKL5 gene therapy trial.</p>
            <a href="donate.html" class="donate-btn">
                üíú Donate Now
            </a>
            <p class="goal-text">Goal: $3.5 Million for Phase I & Phase II</p>
        </section>

    </main>

    <div data-include="inc/footer.html"></div>

    <!-- Back to Top Button -->
    <button id="backToTop" class="back-to-top" title="Back to top">
        <svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2.5" stroke-linecap="round" stroke-linejoin="round">
            <polyline points="18 15 12 9 6 15"></polyline>
        </svg>
    </button>

    <!-- PDF Download Modal -->
    <div id="pdfDownloadModal" class="pdf-modal">
        <div class="pdf-modal-content">
            <button class="pdf-modal-close" onclick="closePdfModal()">&times;</button>
            <h3>üìÑ Download Clinical Trial Readiness Overview</h3>
            <p>Please provide your details to access this document. We'd love to keep you updated on our progress!</p>
            
            <form name="pdf-download-detail" method="POST" data-netlify="true" netlify-honeypot="bot-field" id="pdfDownloadForm">
                <input type="hidden" name="form-name" value="pdf-download-detail">
                <input type="hidden" name="pdf-requested" value="Clinical Trial Readiness Overview - Jan 2026">
                <p style="display:none;"><input name="bot-field"></p>
                
                <div class="pdf-form-group">
                    <label for="pdf-name">Your Name *</label>
                    <input type="text" id="pdf-name" name="name" required placeholder="Enter your full name">
                </div>
                
                <div class="pdf-form-group">
                    <label for="pdf-email">Email Address *</label>
                    <input type="email" id="pdf-email" name="email" required placeholder="your@email.com">
                </div>
                
                <div class="pdf-form-group">
                    <label for="pdf-reason">Why are you interested in this document? *</label>
                    <select id="pdf-reason" name="reason" required>
                        <option value="">-- Select an option --</option>
                        <option value="Parent/Caregiver of CDKL5 child">Parent/Caregiver of CDKL5 child</option>
                        <option value="Medical Professional">Medical Professional</option>
                        <option value="Researcher">Researcher</option>
                        <option value="Potential Donor/Supporter">Potential Donor/Supporter</option>
                        <option value="Journalist/Media">Journalist/Media</option>
                        <option value="Other">Other</option>
                    </select>
                </div>
                
                <div class="pdf-form-group" id="otherReasonGroup" style="display: none;">
                    <label for="pdf-other-reason">Please specify:</label>
                    <textarea id="pdf-other-reason" name="other-reason" placeholder="Tell us more..."></textarea>
                </div>
                
                <button type="submit" class="pdf-submit-btn">
                    <svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2">
                        <path d="M21 15v4a2 2 0 0 1-2 2H5a2 2 0 0 1-2-2v-4"></path>
                        <polyline points="7 10 12 15 17 10"></polyline>
                        <line x1="12" y1="15" x2="12" y2="3"></line>
                    </svg>
                    Submit & Download PDF
                </button>
            </form>
        </div>
    </div>

    <script src="js/includes-loader.js"></script>
    <script src="js/script.js"></script>
    <script>
        const pdfLink = 'documents/cdkl5_gene_therapy_15-jan-2026_ng.pdf';
        
        function openPdfModal() {
            document.getElementById('pdfDownloadModal').classList.add('active');
            document.body.style.overflow = 'hidden';
        }
        
        function closePdfModal() {
            document.getElementById('pdfDownloadModal').classList.remove('active');
            document.body.style.overflow = '';
        }
        
        // Close modal on outside click
        document.getElementById('pdfDownloadModal').addEventListener('click', function(e) {
            if (e.target === this) {
                closePdfModal();
            }
        });
        
        // Show/hide "Other" reason field
        document.getElementById('pdf-reason').addEventListener('change', function() {
            const otherGroup = document.getElementById('otherReasonGroup');
            otherGroup.style.display = this.value === 'Other' ? 'block' : 'none';
        });
        
        // Handle form submission
        document.getElementById('pdfDownloadForm').addEventListener('submit', function(e) {
            e.preventDefault();
            
            const formData = new FormData(this);
            
            fetch('/', {
                method: 'POST',
                headers: { 'Content-Type': 'application/x-www-form-urlencoded' },
                body: new URLSearchParams(formData).toString()
            })
            .then(() => {
                // Download the PDF
                const link = document.createElement('a');
                link.href = pdfLink;
                link.download = 'CDKL5 Gene Therapy Synopsis of the Clinical Team Dinner.pdf';
                link.target = '_blank';
                document.body.appendChild(link);
                link.click();
                document.body.removeChild(link);
                
                // Close modal and reset form
                closePdfModal();
                document.getElementById('pdfDownloadForm').reset();
                
                // Show thank you message
                alert('Thank you! Your download should begin shortly.');
            })
            .catch(err => {
                console.error('Form submission error:', err);
                alert('There was an error. Please try again.');
            });
        });
        
        // Back to Top button functionality
        const backToTopBtn = document.getElementById('backToTop');
        
        window.addEventListener('scroll', function() {
            if (window.pageYOffset > 400) {
                backToTopBtn.classList.add('visible');
            } else {
                backToTopBtn.classList.remove('visible');
            }
        });
        
        backToTopBtn.addEventListener('click', function() {
            window.scrollTo({ top: 0, behavior: 'smooth' });
        });

        // Photo Gallery Slider
        let currentSlide = 0;
        const totalSlides = 7;
        const slides = document.getElementById('gallerySlides');
        const dots = document.querySelectorAll('.gallery-dot');

        function updateGallery() {
            slides.style.transform = `translateX(-${currentSlide * 100}%)`;
            dots.forEach((dot, index) => {
                dot.classList.toggle('active', index === currentSlide);
            });
        }

        function changeSlide(direction) {
            currentSlide += direction;
            if (currentSlide < 0) currentSlide = totalSlides - 1;
            if (currentSlide >= totalSlides) currentSlide = 0;
            updateGallery();
        }

        function goToSlide(index) {
            currentSlide = index;
            updateGallery();
        }

        // Auto-advance every 5 seconds
        let autoSlide = setInterval(() => changeSlide(1), 5000);

        // Pause auto-advance on hover
        document.querySelector('.gallery-container').addEventListener('mouseenter', () => {
            clearInterval(autoSlide);
        });

        document.querySelector('.gallery-container').addEventListener('mouseleave', () => {
            autoSlide = setInterval(() => changeSlide(1), 5000);
        });
    </script>
</body>
</html>
